CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)
CUSIP: 14888U101
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,180,519
- Total 13F shares
- 54,196,334
- Share change
- -512,358
- Total reported value
- $169,201,579
- Put/Call ratio
- 44%
- Price per share
- $3.12
- Number of holders
- 98
- Value change
- +$2,782,969
- Number of buys
- 62
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 14888U101:
Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Broadfin Capital, LLC |
13F
|
Company |
5.5%
|
6,812,764
|
$16,283,000 | — | 31 Mar 2018 | |
| Consonance Capital Management LP |
13F
|
Company |
4.1%
|
4,994,719
|
$11,937,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.8%
|
4,698,531
|
$11,230,000 | — | 31 Mar 2018 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
3.8%
|
4,692,343
|
$11,215,000 | — | 31 Mar 2018 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.6%
|
4,381,072
|
$10,471,000 | — | 31 Mar 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
3,977,907
|
$9,507,000 | — | 31 Mar 2018 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
2.2%
|
2,695,742
|
$6,443,000 | — | 31 Mar 2018 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
1.2%
|
1,508,309
|
$3,605,000 | — | 31 Mar 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
1,389,500
|
$3,321,000 | — | 31 Mar 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,382,258
|
$3,304,000 | — | 31 Mar 2018 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.1%
|
1,346,316
|
$3,218,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.98%
|
1,203,640
|
$2,876,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.96%
|
1,185,384
|
$2,833,000 | — | 31 Mar 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.94%
|
1,153,053
|
$2,756,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.82%
|
1,009,947
|
$2,414,000 | — | 31 Mar 2018 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.76%
|
938,078
|
$2,242,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
855,848
|
$2,045,000 | — | 31 Mar 2018 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.66%
|
816,571
|
$1,952,000 | — | 31 Mar 2018 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.65%
|
802,697
|
$1,918,000 | — | 31 Mar 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.62%
|
763,976
|
$1,825,000 | — | 31 Mar 2018 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.53%
|
651,599
|
$1,557,000 | — | 31 Mar 2018 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.45%
|
550,000
|
$1,315,000 | — | 31 Mar 2018 | |
| David M. Knott |
13F
|
Individual |
0.4%
|
488,575
|
$1,168,000 | — | 31 Mar 2018 | |
| GABLES CAPITAL MANAGEMENT INC. |
13F
|
Company |
0.37%
|
458,864
|
$1,097,000 | — | 31 Mar 2018 | |
| JBF Capital, Inc. |
13F
|
Company |
0.37%
|
458,600
|
$1,096,000 | — | 31 Mar 2018 | |
| Crestline Management, LP |
13F
|
Company |
0.36%
|
446,702
|
$1,068,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.35%
|
436,652
|
$1,043,000 | — | 31 Mar 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.29%
|
355,327
|
$849,000 | — | 31 Mar 2018 | |
| TANAKA CAPITAL MANAGEMENT INC |
13F
|
Company |
0.21%
|
256,593
|
$613,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
237,424
|
$568,000 | — | 31 Mar 2018 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.19%
|
236,901
|
$566,000 | — | 31 Mar 2018 | |
| AJO, LP |
13F
|
Company |
0.19%
|
234,768
|
$561,000 | — | 31 Mar 2018 | |
| STRS OHIO |
13F
|
Company |
0.18%
|
223,100
|
$533,000 | — | 31 Mar 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
184,904
|
$442,000 | — | 31 Mar 2018 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.14%
|
173,670
|
$415,000 | — | 31 Mar 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.13%
|
165,060
|
$394,000 | — | 31 Mar 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.13%
|
165,000
|
$394,000 | — | 31 Mar 2018 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.12%
|
148,055
|
$354,000 | — | 31 Mar 2018 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.11%
|
137,441
|
$328,000 | — | 31 Mar 2018 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.11%
|
133,262
|
$318,000 | — | 31 Mar 2018 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.1%
|
128,500
|
$307,000 | — | 31 Mar 2018 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
123,000
|
$294,000 | — | 31 Mar 2018 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.09%
|
109,954
|
$262,000 | — | 31 Mar 2018 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.09%
|
108,948
|
$260,000 | — | 31 Mar 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
101,453
|
$242,000 | — | 31 Mar 2018 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.08%
|
96,196
|
$230,000 | — | 31 Mar 2018 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.06%
|
74,994
|
$179,000 | — | 31 Mar 2018 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.06%
|
68,058
|
$162,000 | — | 31 Mar 2018 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
67,342
|
$161,000 | — | 31 Mar 2018 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
66,300
|
$158,000 | — | 31 Mar 2018 |
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2018
As of 30 Jun 2018,
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,196,334 shares.
The largest 10 holders included
Broadfin Capital, LLC, BlackRock Inc., Consonance Capital Management LP, venBio Select Advisor LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, MORGAN STANLEY, ARMISTICE CAPITAL, LLC, MANGROVE PARTNERS, and MILLENNIUM MANAGEMENT LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
97
Q2 2018 holders
98
Holder diff
1
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.